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Abstract 
A very little subset of patients diagnosed with interstitial nephritis have the tubulointerstitial nephritis 
and uveitis (TINU syndrome). A considerable number of cases have been documented in the pediatric 
nephrology and ophthalmology literature. We report a 12-year-old girl who presented with a history of 
allergic/drug-induced tubulointerstitial nephritis and diagnosed months later to have uveitis after 
stopping steroids. This considered a very rare combination and the diagnosis of tubulointerstitial 
nephritis and uveitis syndrome was established. She was treated successfully with topical steroid and 
topical cycloplegic agent for about 7 weeks. About 250 cases have been reported worldwide, and this is 
the first reported case in Jordan. 
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1. Introduction 
Tubulointerstitial nephritis (TIN) is a primary injury of both renal tubules and interstitium leading to a 
decrease in renal function. The acute form is more common. More than 95% of cases result from 
infection or an allergic drug reaction. 
Tubulointerstitial Nephritis and Uveitis Syndrome depicts a rare form of non-granulomatous bilateral 
anterior uveitis found in a subgroup of patients affected with tubulointerstitial nephritis. It may precede, 
www.scholink.org/ojs/index.php/rhs                   Research in Health Science                         Vol. 5, No. 1, 2020 
28 
Published by SCHOLINK INC. 
follow or develop simultaneously with uveitis. It was first described by Dobrin et al. (1975), Grefer and 
Dusek et al. (1985) gave the name tubulointerstitial nephritis and uveitis syndrome (TINU) (Grefer et 
al., 1999). More than 250 cases have been reported until now (Abed, Merouani, Haddad, Benoit, Oligny, 
& Sartelet, 2008; Li, Su, Chu, Li, & Yang, 2014). Altogether, more than 100 cases have been reported in 
Japan in which TINU syndrome is considered the second most frequent diagnosis in children with 
uveitis after sarcoidosis (Goda, Kotake, Ichiishi, Namba, Kitaichi, & Ohno, 2005). The uveitis is 
generally mild and the nephritis self-limited. However, cases of chronic uveitis and renal failure have 
been reported. 
 
2. Case Presentation 
A 12-year-old female patient, not known to have any medical problems presented to the emergency 
department with a history of decreased oral intake, nausea, urgency, suprapubic pain, malodorous urine 
and dysuria for one week. Her labs revealed normal CBC, elevated CRP (41.8 mg/L), turbidity in urine 
with high WBCs (550), RBCs (100), +1 protein, +1 glucose, with the presence of bacteria, nitrite, and 
epithelial cells. She was managed as a case of acute bacterial cystitis started on intravenous fluids, 
antiemetic (Ondansetron 0.15 mg/kg) and 1g ceftriaxone in the ER for 2 days followed by once a day 
oral cefixime (8 mg/kg/day) for another 5 days as urine culture revealed bacterial growth. 
Six weeks later, she presented again to the ER, complaining of decreased activity, fatigue, malaise, 
anorexia, weight loss (about 4 kg in 6 weeks) along with episodes of nausea, vomiting, flank pain, 
oliguria, skin rash and low-grade fever for 5 days. Her labs showed Hb of (8.6 g/dl), WBCs (6.37 X 
109/L), eosinophilia (> 5%), ASO titer (500), creatinine (2.78 mg/dl), urea (25 mg/dl), serum 
phosphorus (3.95 mg/dl), serum bicarbonate (15.4 mg/dl), vitamin D (7 ng/ml), urine analysis revealed 
+1 protein with + 1 glucose, and a negative urine culture after 3 days. Abdominal ultrasound showed 
enlargement of both kidneys (10.5-10.8 cm) with increased parenchymal thickness and echogenicity 
with no signs for obstructive uropathy, hence she was admitted to the hospital by her pediatrician.  
After the stabilization of her condition, she underwent a kidney biopsy which revealed diffuse 
interstitial nephritis with infiltration of eosinophil, macrophages, lymphocytes and plasma cells without 
evidence of granuloma, also the immunofluorescent evaluation of the biopsy was negative for IgG, IgM, 
IgA, C3, C4, C1q and fibrin. She was diagnosed with acute tubulointerstitial nephritis and received 
three intravenous doses of 500 mg methylprednisolone over one hour once daily for three days. After 5 
days, she was discharged on 1 mg/kg/day (40 mg) of oral prednisolone, famotidine 20 mg/day, calcium 
500 mg/day, iron syrup (0.48 mg/kg/day), vitamin D 500 IU/day, and one-alpha 0.25 mic/day. After 1 
month as her kidney function recovered, the dose was tapered to 5 mg weekly over the next 2 months. 
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Figure 1. A and B: Renal Biopsy for the Patient Reveals Acute Allergic/ Drug-induced 
Tubulointerstitial Nephritis and Contains Normal Glomeruli 
The interstitium shows generalized edema with minimal fibrosis and dense infiltration by lymphocytes, 
plasma cells, macrophages, and eosinophils. The tubules show epithelial damage and luminal white 
blood cells. The blood vessels are normal. 
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The patient presented to our ophthalmology clinic with bilateral epiphora, photophobia, and eye 
redness. She was complaining of red-eye the week before, accordingly, she was diagnosed to have viral 
conjunctivitis and treated with lubricating eye drops by a general practitioner. 
Upon examination, the best-corrected visual acuity was 20/40 for her right and left eyes. Slit-lamp 
examination showed severe limbal injection bilaterally with corneal edema, +4 anterior chamber cells, 
flare, fine diffuse endothelial precipitates, and severe inflammatory membrane clumped to both irides 
with posterior synechia. 
Further detailed questioning led us to the history of kidney insult about 4 months ago and apparently, 
her eye symptoms started 2 weeks after stopping oral steroids. To exclude the other systemic diseases 
that can cause uveitis such as sarcoidosis Sjögren’s syndrome, systemic lupus erythematosus, Behçet’s 
syndrome, Wegener’s granulomatosis, immunoglobulin G4 (IgG4)-related autoimmune disease, and 
infectious diseases, further testing were performed ANA, c-ANCA, p- ANCA, Anti-ds DNA, Anti Ro, 
Anti La, QuantiFERON-TB Gold test (QFT-G), IgG4 serum level, angiotensin-converting enzyme 
level, infectious diseases serological tests and chest X-ray all were negative or within normal limits. 
The patient was started on topical corticosteroids every two hours and topical cycloplegic eye drops 
three times a day then referred to her nephrologist to reassess. One week later the anterior chamber 
reaction dropped to +2 cells, the inflammatory membrane had nearly disappeared and the fundus exam 
was normal. After two weeks her eyes were quiet, her best-corrected vision was 20/20 for both eyes, 
and her labs were within normal limits. The topical cycloplegic agent was stopped and the topical 
corticosteroid was tapered over the next 4 weeks. 
The diagnosis of tubulointerstitial nephritis and uveitis (TINU) syndrome was established and she was 
followed up regularly.  
 
3. Discussion  
Tubulointerstitial Nephritis and Uveitis (TINU) syndrome is a rare oculorenal inflammatory disease 
accounting for less than 1-2% of all patients presenting to ophthalmology (Mackensen & Billing, 2009). 
The true prevalence is unknown exactly and supposedly be higher because undiagnosed cases are 
considered idiopathic. On average, TINU occurs in approximately 65% of patients with TIN (Mandeville, 
Levinson, & Holland, 2001) in whom renal tubular defects are found usually. The mean age of 
presentation is 15 years with female to male ratio 3:1 (Mandeville, Levinson, & Holland, 2001). There is 
an increased proportion of affected males in recent reports (Sinnamon, Courtney, & Harron, 2008) with a 
trend towards a male predominance in younger age groups (Yoshioka, Takemura, Kanasaki, Akano, & 
Maki, 1991). There is no association with particular racial or ethnic groups, or geographical distribution 
(Mandeville, Levinson, & Holland, 2001; Mackensen et al., 2011). 
The cause of TINU is unknown but various associations had revealed in researches. Certain HLA 
genotypes (including HLA-DQA1and DRB1) increase the relative risk of developing TINU in certain 
populations (Yoshioka, Takemura, Kanasaki, Akano, & Maki, 1991; Mackensen et al., 2011). In addition, 
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medications have been implicated as antibiotics or NSAIDs. The drug causing hapten-induced cytokine 
production or hypersensitivity and immune reaction. Another possibility correlated to dysfunction or 
targeted disruption of similar enzymes in the renal tubule and ciliary epithelium. 
The underlying mechanisms for TINU are not fully recognized yet. Limited data suggest that modified 
C-reactive protein (mCRP), an autoantigen common to both the uvea and renal tubular cells, may play a 
role in the pathogenesis (Tan et al., 2011). In a study of 97 patients with various renal disorders and 40 
healthy controls, the prevalence of immunoglobulin G (IgG) antibodies directed against CRP was 
significantly higher among nine patients with TINU syndrome (100%) than among those with Sjögren’s 
associated interstitial nephritis (29%), drug-induced interstitial nephritis (36%), glomerulonephritis (5%), 
and healthy controls (0 percent) (Tan et al., 2011). Another study by the same group proved that patients 
with TINU syndrome and late-onset uveitis had a higher level of mCRP compared with those with 
drug-induced interstitial nephritis (Li, Su, Chu, Li, & Yang, 2014).  
The inflammation in TINU syndrome is thought to be induced by T-lymphocyte mainly, based upon the 
histology. In contrast, immune cells in patients with TINU syndrome have a paradoxical suppression of 
cytokine production and a decrease in the peripheral immune response. This paradox is not unique to 
TINU, as the presence of increased tissue inflammation with concomitant suppression of peripheral 
immunity is also seen in patients with sarcoidosis (Gafter et al., 1993; Levinson et al., 2003). 
No identifiable risk factors are known at least in 50 percent of cases. In some patients, prior infection or 
the use of specific drugs (antibiotics and nonsteroidal anti-inflammatory drugs (NSAIDs)) has been 
implicated (Li, Su, Chu, Li, & Yang, 2014; Mandeville, Levinson, & Holland, 2001). The Chinese herb, 
“Goreisan”, was reported as a trigger (Suzuki et al., 2009). Concurrent Chlamydia and Epstein-Barr virus 
infections have been described (Grefer et al., 1999; Stupp, Mihatsch, Matter, & Streuli, 1990). TINU 
syndrome has also been reported in patients with autoimmune diseases like hypothyroidism, 
hypoparathyroidism, rheumatoid arthritis, and immunoglobulin G4 (IgG4)-related diseases (Catalano et 
al., 1989). 
 Patients usually present with typical anterior uveitis symptoms like (eye pain, redness, and photophobia). 
Symptoms of TIN are not always clear and include malaise, fever, fatigue, and loin pain or tenderness. 
The general malaise usually precedes the ocular findings. The ocular symptoms can precede (21%) by up 
to two months (Yoshioka, Takemura, Kanasaki, Akano, & Maki, 1991), occur concurrently (15%) or 
follow TIN (65%).  
More than 80% of cases with bilateral acute, anterior, non-granulomatous uveitis, however, few cases of 
posterior uveitis and panuveitis were reported (Mackensen & Billing, 2009; Mandeville, Levinson, & 
Holland, 2001). In 2006 a case of nodular scleritis preceding TINU syndrome in adults was reported 
indicating that episcleritis may be part of the ocular inflammation occurring in TINU syndrome (Daniel, 
Gangaputra, Kempen, & Jabs, 2006). In 2001 Mandeville et al have published the evaluation criteria for 
the TINU syndrome (Mandeville, Levinson, & Holland, 2001) depend on the presence of acute 
interstitial nephritis and uveitis, without any underlying disease, in addition to the following: abnormal 
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kidney function test, abnormal urinalysis, and Systemic disease duration of at least 2 weeks. 
The differential diagnosis of TINU is a crucial issue to know, as it is important to exclude any systemic 
causes. This list of differential may include sarcoidosis, Behcet’s disease, systemic lupus erythematosus 
Wegener’s granulomatosis, Sjogren’s syndrome primary hyperparathyroidism, hyperthyroidism, and 
infectious causes. A reliable diagnosis can be made from proper ophthalmic exam and laboratory 
evaluation. However, a definitive diagnosis can only be established with renal biopsy (Helms, Servilla, 
Hartshorne, Harris, Nichols, & Tzamaloukas, 2005). In addition, beta-2 microglobulin, eosinophils, 
proteinuria, hematuria, pyuria, white cells casts, and normoglycemic glucosuria may be detected. The 
ANCA, anticardiolipin antibodies, anti-DNA antibody, antinuclear antibody, and rheumatoid factor 
could be positive in addition to hypocomplementemia, polyclonal hypergammaglobulinemia and 
circulating immune complexes (Goda, Kotake, Ichiishi, Namba, Kitaichi, & Ohno, 2005; Mandeville, 
Levinson, & Holland, 2001; Paladini, Venturoli, Mosconi, Zambianchi, Serra, & Valletta, 2013). 
Although TIN may resolve spontaneously, the corticosteroid is the treatment of choice for patients with 
progressive renal failure. About 11% of nephropathy cases become chronic and no more than 5% of 
patients require dialysis (Hinkle & Foster, 2008). The using of topical steroids with cycloplegic agents 
is recommended for anterior uveitis (Parameswaran et al., 2010; Gion, Stavrou, & Foster, 2000). Some 
refractory cases need oral steroids (Gion, Stavrou, & Foster, 2000; Thomassen, Ring, Thaarup, & 
Baggesen, 2009) or rarely, immunosuppressive agents (Gion, Stavrou, & Foster, 2000; Thomassen, Ring, 
Thaarup, & Baggesen, 2009; Liakopoulos et al., 2006). In 14% of the cases, the symptoms of uveitis 
persist for more than 12 weeks (Liakopoulos et al., 2006) with 50% of recurrence (Yoshioka, Takemura, 
Kanasaki, Akano, & Maki, 1991).  
In our case, the main cause of TIN was allergic/drug-induced, which is thought to be the etiology for 
60-70% of cases (Nat Rev Nephrol., 2010). Multiple drugs from different classes may induce TIN. 
Antibiotics such as cephalosporins, penicillins, sulfonamides, rifampin, and ciprofloxacin accounting 
for about 25% of cases (Praga & Gonzalez, 2010). The cephalosporins were implicated in this case. The 
patient responded well to systemic corticosteroids and her eyes showed improvement with the 
treatment. 
 
4. Conclusion  
Tubulointerstitial nephritis and Uveitis Syndrome is a rare entity that is usually underestimated due to 
the unique presentation, therefore, ophthalmologists should recognize and consider it if the clinical 
history is suspicious. Any patient presented with uveitis and history of tubulointerstitial nephritis, 
especially adolescents, should be investigated and evaluated before establishing the diagnosis of TINU 
syndrome, because uveitis may be due to another unremarkable disease and not related to the 
tubulointerstitial nephritis. 
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